Company: SHPH
Filing Date: 2025-04-10
Form Type: PRER14A
Source: 0001641172-25-003635
Chunk: 13

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-04-10
Form: PRER14A
Chunk 13
---
4: 0*       
 ACTIONS                
 BY WRITTEN CONSENT: 2* |
| George          
 Scorsis (Chair) 
 Steven          
 Richards        
 Oleh            
 Nabyt           |     |                        |

* Messrs. Scorsis and Nabyt joined as the Company’s Board in February 2025. Accordingly, our previous Compensation Committee members took action by written consent for the Compensation Committee in 2024 until their resignations in February 2025.

KEY RESPONSIBILITIES

| ● | Makes                                                                                                                                  
 recommendations to the Board of Directors concerning the salaries and incentive compensation for our officers, including our principal 
 executive officer and employees and administers our stock option plan.                                                                 |

NOMINATING AND CORPORATE GOVERNANCE Committee

| MEMBERS      |     | MEETINGS               
 HELD IN 2024: 0*       
 ACTIONS                
 BY WRITTEN CONSENT: 0* |
| Joseph       
 Tung (Chair) |     |                        |
| George       
 Scorsis      |     |                        |
| Oleh         
 Nabyt        |     |                        |

* Messrs. Tung, Scorsis and Nabyt joined as the Company’s Board in February 2025. Accordingly, our previous Nominating and Corporate Governance Committee members took action by written consent for the Nominating and Corporate Governance Committee in 2024 until their resignations in February 2025.

KEY RESPONSIBILITIES

| ● | Assists                                                                                                                          
 the Board of Directors in identifying qualified individuals to become board members, in determining the composition of the Board 
 of Directors and in monitoring Board of Directors effectiveness.                                                                 |

| 9 |

Considerations in Evaluating Director Nominees

The Board of Directors is responsible for overseeing the Company’s business consistent with its fiduciary duty to the stockholders. This significant responsibility requires highly skilled individuals with various qualities, attributes and professional experience. There are general requirements for service on the Board of Directors that are applicable to directors and there are other skills and experience that should be represented on the Board of Directors as a whole but not necessarily by each director. The Nominating and Corporate Governance Committee considers the qualifications of director candidates individually and in the broader context of the Board of Directors’ overall composition and the Company’s current and future needs.

STOCKholder Recommendations for Nominations to the Board of Directors

We do not currently have a procedure by which security holders may recommend nominees to the Board of Directors. Prior to the listing of